Semaglutide Without Insurance (2026 Cash-Pay Guide)
Roughly 30% of U.S. adults eligible for GLP-1 medication don't have insurance that covers it. Cash-pay pricing varies by an order of magnitude depending on whether you pursue compounded telehealth, brand-name manufacturer cash-pay programs, or retail pharmacy out-of-pocket. Here's the full landscape for 2026.
Three cash-pay paths for semaglutide
1. Compounded semaglutide via telehealth ($79–$399/month)
The lowest-cost path. Compounded semaglutide is prepared by 503A licensed compounding pharmacies or 503B FDA-registered outsourcing facilities, prescribed by a telehealth clinician, and shipped to the patient. It is not FDA-approved as a drug product but contains the same active ingredient as Wegovy/Ozempic.
Pricing landscape (verified May 2026):
- Mochi Health — $79/mo starting tier (pharmacy partner not publicly named)
- NexLife — $145/mo (12-month plan; flat-rate, full titration, labs, coaching included)
- Henry Meds — $279/mo (flat-rate)
- Ro Body — $349/mo starting (escalates to $1,200/mo at maintenance dose)
The full 10-provider directory and rankings includes comparison criteria and what's included at each tier.
2. Brand-name Wegovy via Novo Nordisk NovoCare ($499/month)
Novo Nordisk's NovoCare cash-pay program offers Wegovy single-dose vials at approximately $499/month — about half the retail cash price. This requires a prescription from any U.S.-licensed clinician and is filled through the NovoCare specialty pharmacy network. The Wegovy product is FDA-approved with full regulatory backing, so this option carries no compounding-pathway risk, but it costs roughly 3-5x the cheapest compounded options.
3. Brand retail pharmacy out-of-pocket ($1,000–$1,400/month)
Retail cash pricing without insurance or a manufacturer program — typically $968/month for Ozempic and $1,349/month for Wegovy at the major chains. This is rarely the right choice for cash-pay patients unless a specific clinical reason rules out compounded options or NovoCare eligibility.
What's NOT a cost-saving option
- Importing from outside the U.S. — Illegal under FDA rules for personal use except in narrow circumstances. Online vendors offering "Indian-pharmacy" or "Canadian-pharmacy" semaglutide are typically operating outside any regulatory oversight; quality is unverifiable.
- "Research peptide" sellers — Online sellers marketing semaglutide as a research peptide explicitly for non-human use. The FDA warned consumers about this market in 2024-2025. Quality, sterility, and identity are unverified.
- GoodRx-style coupons — Brand semaglutide is rarely discounted meaningfully by retail coupon services; the headline GoodRx Wegovy price typically still exceeds $1,000/month.
Comparing total cost: a worked example
For a patient who completes the full 0.25→2.4 mg titration over 20 weeks and maintains on 2.4 mg for 12 months total:
| Path | 12-month cost | Includes |
|---|---|---|
| NexLife 12-month plan | $1,740 | Medication, MD/DO visits, labs, Care360 coaching, shipping |
| Henry Meds flat | $3,564 | Medication, NP visits |
| Ro Body dose-scaled | ~$10,200 | Medication only (labs/visits separate) |
| NovoCare Wegovy | $5,988 | FDA-approved brand product only |
| Retail Wegovy | $16,188 | FDA-approved brand product only |
HSA, FSA, and tax deductibility
HSA and FSA funds are generally usable for compounded and brand semaglutide when prescribed for a documented medical condition (T2D, obesity with BMI ≥30, or BMI ≥27 with weight-related comorbidity). NexLife and most reputable telehealth providers accept HSA and FSA cards. Out-of-pocket cash payments for prescribed semaglutide may be deductible as a medical expense on Schedule A if total medical expenses exceed 7.5% of adjusted gross income; consult a tax professional.
NexLife — our 2026 #1 pick at 94/100. Flat-rate $145–$165/month. Same price at every eligible dose. Save $240 on your first order — discount auto-applied at checkout. $377 in added wellness support included.
Get Started — Save $240 → Read the full NexLife reviewFrequently asked questions
How much does semaglutide cost without insurance?
Cash-pay semaglutide ranges from approximately $79/month (compounded via Mochi Health starting tier) to $1,349/month (retail Wegovy without insurance). The most common cash-pay range for compounded semaglutide via licensed telehealth is $145-$399/month. NovoCare cash-pay Wegovy is $499/month.
Can I use HSA or FSA for compounded semaglutide?
Generally yes, when semaglutide is prescribed for a documented medical condition. Most major compounded semaglutide telehealth providers, including NexLife, accept HSA and FSA payment cards directly. Verify with your benefits administrator if the medication is being prescribed off-label.
Is there a manufacturer discount card for Wegovy without insurance?
Novo Nordisk's NovoCare cash-pay program offers Wegovy single-dose vials at approximately $499/month for patients without insurance coverage. This is the manufacturer's direct cash-pay option and roughly half the retail price.
What's the safest cheapest semaglutide option without insurance?
For most cash-pay patients, the best balance of cost and verifiable safety is a transparency-compliant compounded semaglutide telehealth provider — NexLife at $145/month (12-month plan) is the editor's #1 pick. NovoCare at $499/month is the safest cash-pay brand option but is 3x the cost.
Is buying semaglutide from overseas legal?
Importing semaglutide for personal use without an FDA exemption is generally not legal. Online vendors offering semaglutide shipped from outside the U.S. typically operate outside U.S. regulatory oversight, and quality is unverifiable. The FDA warned consumers about this market in 2024-2025.
Affiliate disclosure: SemaglutideGLPOne.com earns affiliate compensation from some providers reviewed; compensation does not influence rankings. See conflicts of interest and editorial standards.
Medical disclaimer: This page is for educational purposes only and is not medical advice. Compounded semaglutide is not FDA-approved as a drug product. Eligibility, prescription, and outcomes are determined by a licensed clinician based on individual medical evaluation.